| |
|
|
|
Brickell Biotech Inc.  
|
|
1.14 -0.03 (-0.03%) |
03-08 16:00 |
|
Open: |
1.15 |
Pre close: |
1.17 |
Target:
|
1.68
|
|
High: |
1.185 |
Low: |
1.1 |
Resistance:
|
1.44
1.70
|
|
Volume: |
1,249,262 |
Market Cap: |
61M |
Support:
|
1.01
0.84
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.18
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
1.37 |
Signal(12,26,9): |
0.03 |
|
MA(100): |
0.92  |
Stochastic Oscillator |
%K(14,3):
|
21.57 |
|
MA(250): |
1.00 |
%D(3): |
19.74 |
|
Average Volume(K) |
3-Month: |
400465
|
52-Week |
High:
|
2.61 |
|
10-Days: |
242940 |
Low: |
0.47 |
|
RSI |
RSI(14):
|
43.09 |
Change(%): |
-36.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.167 |
Return on Equity (ttm) |
-132.2 |
Shares Out. (M) |
53.52 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-51.6 |
Shares Float (M) |
52.46 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.08 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-88.0 |
% Held by Institutions |
10.65 |
|
Forward EPS |
-4.500 |
Gross Profit (p.s.) |
-0.230 |
Shares Short (K) |
4610 |
|
Book Value (p.s.) |
2.330 |
EBITDA (p.s.) |
-0.446 |
P/E |
-0.36 |
|
Sales Per Share |
0.046 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.49 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-29.32 |
P/S |
24.80 |
|
Operating Margin |
-968.39 |
Levered Free Cash Flow
(M) |
-13.56 |
P/CF |
-2.08 |
|
|
|
|
|
|
